Quibim Extends Into US Market With FDA Authorization Of AI Radiology Tool QP-Prostate

The US FDA's clearance of QP-Prostate positions the company to support US health care providers and growing markets for fusion biopsy and focal therapy, said Quibim CEO and founder Angel Alberich-Bayarri.